Baidu
map

RBMO:胚胎筛选新技术可提高试管婴儿成功率

2013-05-22 刘石磊 新华社

胚胎异常是体外受精最终失败的主要原因之一。英国研究人员开发出一种可筛查胚胎质量的新技术,有望提高试管婴儿的成功率。 英国《生殖生物医学在线》杂志刊登这项新成果说,胚胎出现非整倍性变异(即染色体数目错误)等,是体外受精和胚胎移植后最终流产或产下不健康婴儿的重要原因。一家名为“卡利生育组织”的机构发现,这种问题胚胎在早期发育时有两个节点会表现出异常,即从密集束细胞变成微小的囊,以及囊开始充满液体两个

胚胎异常是体外受精最终失败的主要原因之一。英国研究人员开发出一种可筛查胚胎质量的新技术,有望提高试管婴儿的成功率。

英国《生殖生物医学在线》杂志刊登这项新成果说,胚胎出现非整倍性变异(即染色体数目错误)等,是体外受精和胚胎移植后最终流产或产下不健康婴儿的重要原因。一家名为“卡利生育组织”的机构发现,这种问题胚胎在早期发育时有两个节点会表现出异常,即从密集束细胞变成微小的囊,以及囊开始充满液体两个阶段。

研究人员根据这一特性,开发出一套为胚胎健康程度评级的计算机程序,可将早期胚胎染色体异常的风险分为三等。研究人员在实验中评估了88个胚胎的健康风险,结果在被评为“健康风险低”的一组中,有61%最终产下健康婴儿,而被评为高风险的一组则全部失败。

研究人员说,此前只能在体外受精开始后通过细胞数量和形状来判断胚胎的健康程度,而新技术通过对胚胎质量的早期筛查,有望将体外受精并成功生育的概率提高至约78%,成功率比当前同类辅助生育技术高约3倍

Retrospective analysis of outcomes after IVF using an aneuploidy risk model derived from time-lapse imaging without PGS
Time-lapse imaging of human preimplantation IVF embryos has enabled objective algorithms based on novel observations of development (morphokinetics) to be used for clinical selection of embryos. Embryo aneuploidy, a major cause of IVF failure, has been correlated with specific morphokinetic variables used previously to develop an aneuploidy risk classification model. The purpose of this study was to evaluate the effectiveness and potential impact of this model for unselected IVF patients without biopsy and preimplantation genetic screening (PGS). Embryo outcomes – no implantation, fetal heart beat (FHB) and live birth (LB) – of 88 transferred blastocysts were compared according to calculated aneuploidy risk classes (low, medium, high). A significant difference was seen for FHB (P<0.0001) and LB (P<0.01) rates between embryos classified as low and medium risk. Within the low-risk class, relative increases of 74% and 56%, compared with rates for all blastocysts, were observed for FHB and LB respectively. The area under the receiver operating characteristic curve was 0.75 for FHB and 0.74 for LB. This study demonstrates the clinical relevance of the aneuploidy risk classification model and introduces a novel, non-invasive method of embryo selection to yield higher implantation and live birth rates without PGS.
The largest single cause of failure of the human embryo to implant, and of early miscarriage, is aneuploidy (errors in numbers of chromosomes of the early (preimplantation) human embryo). More than half of human embryos are believed to be affected by aneuploidy and many must be unwittingly transferred following IVF, resulting in failed implantation, miscarriage or the birth of a baby with a related disorder. It is not possible for embryologists in IVF laboratories to identify aneuploid embryos under the microscope; however, our studies with time-lapse incubation in conjunction with preimplantation genetic screening (PGS) of IVF embryos have allowed us to develop and publish a model that rates each embryo based on its developmental patterns (morphokinetics) as being at low, medium or high risk of aneuploidy. PGS, whilst very effective, requires expensive technology and expertise, is not widely available and requires the embryo to undergo biopsy (removal of cell(s)). In this study, we tested the aneuploidy risk classification model on embryos with a known outcome and, importantly, on those embryos resulting in a live birth. This demonstrated how the model has the potential to greatly enhance IVF outcome without biopsy and PGS. By using such unique, non-invasive and specifically designed embryo selection models, we can now make more informed choices in order to select the most viable embryo to transfer, with the lowest risk of aneuploidy. Selection of an embryo classified as low risk has improved the relative chance of a live birth by 56% over conventional embryo selection.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903648, encodeId=678b190364867, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sun Feb 02 01:54:00 CST 2014, time=2014-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813110, encodeId=48a81813110b8, content=<a href='/topic/show?id=1fdd91e56f7' target=_blank style='color:#2F92EE;'>#试管婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91756, encryptionId=1fdd91e56f7, topicName=试管婴)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Tue Jun 25 17:54:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315225, encodeId=30ea1315225d9, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584329, encodeId=d8b71584329b1, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903648, encodeId=678b190364867, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sun Feb 02 01:54:00 CST 2014, time=2014-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813110, encodeId=48a81813110b8, content=<a href='/topic/show?id=1fdd91e56f7' target=_blank style='color:#2F92EE;'>#试管婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91756, encryptionId=1fdd91e56f7, topicName=试管婴)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Tue Jun 25 17:54:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315225, encodeId=30ea1315225d9, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584329, encodeId=d8b71584329b1, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-06-25 ying_wu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1903648, encodeId=678b190364867, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sun Feb 02 01:54:00 CST 2014, time=2014-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813110, encodeId=48a81813110b8, content=<a href='/topic/show?id=1fdd91e56f7' target=_blank style='color:#2F92EE;'>#试管婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91756, encryptionId=1fdd91e56f7, topicName=试管婴)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Tue Jun 25 17:54:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315225, encodeId=30ea1315225d9, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584329, encodeId=d8b71584329b1, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-05-24 ailian1202
  4. [GetPortalCommentsPageByObjectIdResponse(id=1903648, encodeId=678b190364867, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Sun Feb 02 01:54:00 CST 2014, time=2014-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813110, encodeId=48a81813110b8, content=<a href='/topic/show?id=1fdd91e56f7' target=_blank style='color:#2F92EE;'>#试管婴#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91756, encryptionId=1fdd91e56f7, topicName=试管婴)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Tue Jun 25 17:54:00 CST 2013, time=2013-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315225, encodeId=30ea1315225d9, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584329, encodeId=d8b71584329b1, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Fri May 24 01:54:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]

相关资讯

试管婴儿或增加儿童哮喘风险

作者:Lara C. Pullen, PhD         比起正常出生的孩子,经历更长时间受孕过程的孩子更容易患哮喘,有更多的病例在去年发生过喘鸣并提前预备了抗哮喘药物。在辅助生殖技术(ART)帮助下出生的孩子尤其如此。研究人员无法解释这种关联背后的机制。        12月

试管婴儿之父罗伯特爱德华兹逝世

  罗伯特·爱德华兹   据英国广播公司(BBC)最新报道,“试管婴儿之父”、2010年诺贝尔生理学或医学奖得主罗伯特·爱德华兹4月10日不幸逝世,享年87岁。   据剑桥大学官方声明称,“经历了长时间的病痛之后,爱德华兹在睡梦中安静地逝去”。   因为在人类试管授精(IVF)疗法上的卓越贡献,罗伯特·爱德华兹荣获了2010年度诺贝尔生理学或医学奖。他的贡献使治疗不育症成为可能,包括全球超过

Baidu
map
Baidu
map
Baidu
map